tiprankstipranks
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Alnylam Pharma (ALNY) Ownership - Who Owns Alnylam Pharma?

1,032 Followers

Alnylam Pharma (ALNY) Ownership Overview

16.45%48.64%14.25%20.66%
16.45% Insiders
14.25% Other Institutional Investors
20.66% Public Companies and Individual Investors
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail and individual investors. Approximately 62.89% of the company’s stock is owned by Institutional Investors, 16.45% is owned by Insiders and 20.66% is owned by Public Companies and Individual Investors.
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail and individual investors. Approximately 62.89% of the company’s stock is owned by Institutional Investors, 16.45% is owned by Insiders and 20.66% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 20, 2024Sold$149397
Feb 20, 2024
Pushkal Garg
Cmo & Evp Dev & Med Affairs
Sold$193666
Feb 20, 2024Sold$149099
Feb 20, 2024
Yvonne Greenstreet
Ceo,director
Sold$1040885

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$193898
Dec 31, 2023Bought$301279
Dec 31, 2023Bought$373440
Dec 31, 2023Sold$887185

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,451,363Institution9.06%1,664,112,071
10,687,316Institution8.45%1,553,080,761
10,256,633Insider8.11%1,490,493,908
8,122,013Institution6.42%1,180,290,929
5,524,903Institution4.37%802,878,904
3,674,310Institution2.91%533,950,729
3,493,304Institution2.76%507,646,937
3,326,323Institution2.63%483,381,258
3,318,681Institution2.62%482,270,723
2,791,341Institution2.21%405,637,674

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,687,316Institution8.45%1,553,080,761
8,122,013Institution6.42%1,180,290,929
5,524,903Institution4.37%802,878,904
3,326,323Institution2.63%483,381,258
3,318,681Institution2.62%482,270,723
2,791,341Institution2.21%405,637,674
2,636,860Institution2.09%383,188,495
2,626,264Institution2.08%381,648,684
2,068,831Institution1.64%300,642,521
1,670,800Institution1.32%242,800,656

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,965,936Institution3.14%592,709,135
2,606,403Institution2.06%389,526,928
1,878,178Institution1.49%280,693,702
1,207,940Institution0.96%180,526,633
939,725Institution0.74%136,560,837
894,645Institution0.71%133,704,695
486,154Institution0.38%71,328,515
465,511Institution0.37%67,648,059
402,584Institution0.32%60,166,179
376,990Institution0.30%54,784,187

FAQ

Who Owns Alnylam Pharmaceuticals (ALNY)?
According to the latest TipRanks data, approximately 14.25% of the company's stock is held by institutional investors, 16.45% is held by insiders, and 20.66% is held by retail investors.
    What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 14.25% of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors.
      What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.66% of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors.
        Who owns the most shares of Alnylam Pharmaceuticals (ALNY)?
        Vanguard owns the most shares of Alnylam Pharmaceuticals (ALNY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis